Sun Pharmaceutical (SUNPHARMA) — Board Meeting

Sun Pharmaceutical filed its FY2024-25 Sustainability Report on February 2, 2026, achieving top 5% ranking among global pharmaceutical companies in S&P Global Sustainability Yearbook. The company delivered 21% absolute carbon reduction and 48% intensity reduction versus 2020 baseline, with renewable energy at 41% of consumption. CSR spending reached ₹1,424 million, impacting 4.47 million lives. Revenue stood at ₹854,629 million ($6.2 billion) with ₹32.48 billion R&D investment. The report covers ESG performance across 79% of operating sites with external DNV assurance, highlighting zero environmental non-compliance and a 62.5% independent board.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this board meeting affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 2 February 2026?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 2 February 2026

TATASTEEL Tata Steel Limited Announcement VEDL Vedanta Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results ASIANPAINT Asian Paints Limited Financial Results AXISBANK Axis Bank Limited Financial Results CANBK Canara Bank Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.